Anna Protopapas
2021
Compensation breakdown
| Non-Equity Incentive Plan | $276,086 |
|---|---|
| Option Awards | $5,632,504 |
| Salary | $569,250 |
| Stock Awards | $1,792,650 |
| Other | $7,000 |
| Total | $8,277,490 |
Protopapas received $5.6M in option awards, accounting for 68% of the total pay in 2021.
Protopapas also received $276.1K in non-equity incentive plan, $569.3K in salary, $1.8M in stock awards and $7K in other compensation.
Rankings
In 2021, Anna Protopapas' compensation ranked 1,383rd out of 12,415 executives tracked by ExecPay. In other words, Protopapas earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,383 out of 12,415 | 89th |
Division Manufacturing | 498 out of 5,505 | 91st |
Major group Chemicals And Allied Products | 182 out of 2,375 | 92nd |
Industry group Drugs | 152 out of 2,096 | 93rd |
Industry Pharmaceutical Preparations | 101 out of 1,546 | 94th |
Pay ratio
| Anna Protopapas' Pay | $8,277,490 |
|---|---|
| Median Employee's Pay | $302,642 |
| Pay Ratio | 27to 1 |
In 2021, the annual total compensation of Anna Protopapas was $8,277,490.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Anna Protopapas' pay to the pay of median employee was therefore 27 to one.
Protopapas' colleagues
We found six more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2021.
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2021
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
2021
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2021
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
2021
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020
April 23, 2019